Skip to main content
OpenTrials
Completed

NCT Number: NCT06468150

Mechanical Thrombectomy and Catheter Directed Thrombolysis Utilization in Patients With Deep Vein Thrombosis

The goal of this observational study is to assess the utilization of mechanical thrombectomy and catheter-directed thrombolysis in patients with deep vein thrombosis in tertiary care. The main questions it aims to answer are:

1. How many patients with deep vein thrombosis are potentially eligible for mechanical thrombectomy and catheter-directed thrombolysis in a tertiary hospital? 2. What is the actual number of patients undergoing endovascular interventions for deep vein thrombosis?

Participants received endovascular treatment according to the clinical protocol of the treatment.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

The Federal Budget-Funded Institution National Medical Surgical Center named after N. I. Pirogov of the Ministry of health of the Russian Federation

Moscow, 117997, Russia

About this study

Tertiary hospital database was analyzed. All the records of patients referred for deep vein thrombosis were extracted. The collected data included general patient information, medical history, results of physical examination, duplex ultrasound, laboratory analysis, etc. Indications and contraindications for mechanical thrombectomy and catheter-directed thrombolysis were assessed, considering possible benefits and risks. Patients who could be eligible for this technique were identified

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • lower limb, pelvic, or inferior vena cava deep vein thrombosis

Exclusion criteria

-

Treatment and study plan

Primary outcomes

  1. Number of patients with deep vein thrombosis who could be eligible for mechanical thrombectomy and catheter-directed thrombolysis

    Time frame: from date of admission until the date of discharge, up to 1-2 weeks

    The number of participants with deep vein thrombosis who would fit the eligibility criteria for performing the intervention

Secondary outcomes

  1. The number of patients with deep vein thrombosis who underwent mechanical thrombectomy and catheter-directed thrombolysis

    Time frame: from date of admission until the date of discharge, up to 1-2 weeks

    The number of participants with deep vein thrombosis who fitted the eligibility criteria and underwent the intervention.

Sponsors and collaborators

Lead sponsor

Pirogov Russian National Research Medical University

Other

Registry information

Important dates

Study start
2022
Primary completion
2023
Study completion
2024
First posted
Jun 21, 2024
Registry last updated
Jun 21, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.